(V) Visa - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US92826C8394
Stock:
Total Rating 50
Risk 89
Buy Signal 0.04
| Risk 5d forecast | |
|---|---|
| Volatility | 20.9% |
| Relative Tail Risk | -0.82% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.46 |
| Alpha | -21.91 |
| Character TTM | |
|---|---|
| Beta | 0.775 |
| Beta Downside | 0.666 |
| Drawdowns 3y | |
|---|---|
| Max DD | 17.41% |
| CAGR/Max DD | 0.79 |
EPS (Earnings per Share)
Revenue
Description: V Visa
Visa Inc. operates as a payment technology company in the United States and internationally. The company operates VisaNet, a transaction processing network that enables authorization, clearing, and settlement of payment transactions. It also offers credit, debit, and prepaid card products; tap to pay, tokenization, and click to pay services; Visa Direct, a platform which facilitates money movement, enabling clients to collect, hold, convert, and send funds across its network; and issuing solutions, such as airport lounge access, dining reservations, shopping experiences, event tickets, and seller offers. In addition, the company provides acceptance solutions, an omnichannel payment integration with e-commerce platforms; risk detection and prevention solutions; and advisory and other services comprising consulting practice, proprietary analytics models, data scientists and economists, marketing services, and managed services. It provides its services under the Visa, Visa Electron, V PAY, Interlink, and PLUS brands. The company serves consumers, sellers, financial institutions, and government entities. Visa Inc. was founded in 1958 and is headquartered in San Francisco, California.
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income: 20.79b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.24 > 0.02 and ΔFCF/TA 1.48 > 1.0 |
| NWC/Revenue: 8.47% < 20% (prev 9.59%; Δ -1.12% < -1%) |
| CFO/TA 0.25 > 3% & CFO 24.44b > Net Income 20.79b |
| Net Debt (6.42b) to EBITDA (26.59b): 0.24 < 3 |
| Current Ratio: 1.11 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.93b) vs 12m ago -2.62% < -2% |
| Gross Margin: 81.08% > 18% (prev 0.79%; Δ 8029 % > 0.5%) |
| Asset Turnover: 43.87% > 50% (prev 40.05%; Δ 3.82% > 0%) |
| Interest Coverage Ratio: 42.13 > 6 (EBITDA TTM 26.59b / Interest Expense TTM 601.0m) |
Altman Z'' 2.87
| A: 0.04 (Total Current Assets 35.00b - Total Current Liabilities 31.49b) / Total Assets 96.81b |
| B: 0.17 (Retained Earnings 16.02b / Total Assets 96.81b) |
| C: 0.27 (EBIT TTM 25.32b / Avg Total Assets 94.35b) |
| D: 0.28 (Book Value of Equity 16.27b / Total Liabilities 58.04b) |
| Altman-Z'' Score: 2.87 = A |
Beneish M -3.45
| DSRI: 0.46 (Receivables 3.23b/6.27b, Revenue 41.39b/36.80b) |
| GMI: 0.98 (GM 81.08% / 79.21%) |
| AQI: 0.99 (AQ_t 0.59 / AQ_t-1 0.60) |
| SGI: 1.12 (Revenue 41.39b / 36.80b) |
| TATA: -0.04 (NI 20.79b - CFO 24.44b) / TA 96.81b) |
| Beneish M-Score: -3.45 (Cap -4..+1) = AA |
What is the price of V shares?
As of February 28, 2026, the stock is trading at USD 320.14 with a total of 12,411,361 shares traded.
Over the past week, the price has changed by -0.25%, over one month by -1.37%, over three months by -4.08% and over the past year by -9.33%.
Over the past week, the price has changed by -0.25%, over one month by -1.37%, over three months by -4.08% and over the past year by -9.33%.
Is V a buy, sell or hold?
Visa has received a consensus analysts rating of 4.34.
Therefore, it is recommended to buy V.
- StrongBuy: 23
- Buy: 10
- Hold: 7
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the V price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 400.8 | 25.2% |
| Analysts Target Price | 400.8 | 25.2% |
V Fundamental Data Overview February 28, 2026
P/E Trailing = 29.765
P/E Forward = 26.9542
P/S = 14.7522
P/B = 17.767
P/EG = 1.9739
Revenue TTM = 41.39b USD
EBIT TTM = 25.32b USD
EBITDA TTM = 26.59b USD
Long Term Debt = 19.59b USD (from longTermDebt, last quarter)
Short Term Debt = 1.59b USD (from shortTermDebt, last quarter)
Debt = 21.18b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.42b USD (from netDebt column, last quarter)
Enterprise Value = 617.03b USD (610.61b + Debt 21.18b - CCE 14.76b)
Interest Coverage Ratio = 42.13 (Ebit TTM 25.32b / Interest Expense TTM 601.0m)
EV/FCF = 26.91x (Enterprise Value 617.03b / FCF TTM 22.93b)
FCF Yield = 3.72% (FCF TTM 22.93b / Enterprise Value 617.03b)
FCF Margin = 55.39% (FCF TTM 22.93b / Revenue TTM 41.39b)
Net Margin = 50.23% (Net Income TTM 20.79b / Revenue TTM 41.39b)
Gross Margin = 81.08% ((Revenue TTM 41.39b - Cost of Revenue TTM 7.83b) / Revenue TTM)
Gross Margin QoQ = 81.68% (prev 81.53%)
Tobins Q-Ratio = 6.37 (Enterprise Value 617.03b / Total Assets 96.81b)
Interest Expense / Debt = 0.92% (Interest Expense 194.0m / Debt 21.18b)
Taxrate = 12.98% (873.0m / 6.73b)
NOPAT = 22.03b (EBIT 25.32b * (1 - 12.98%))
Current Ratio = 1.11 (Total Current Assets 35.00b / Total Current Liabilities 31.49b)
Debt / Equity = 0.55 (Debt 21.18b / totalStockholderEquity, last quarter 38.78b)
Debt / EBITDA = 0.24 (Net Debt 6.42b / EBITDA 26.59b)
Debt / FCF = 0.28 (Net Debt 6.42b / FCF TTM 22.93b)
Total Stockholder Equity = 38.34b (last 4 quarters mean from totalStockholderEquity)
RoA = 22.04% (Net Income 20.79b / Total Assets 96.81b)
RoE = 54.22% (Net Income TTM 20.79b / Total Stockholder Equity 38.34b)
RoCE = 43.71% (EBIT 25.32b / Capital Employed (Equity 38.34b + L.T.Debt 19.59b))
RoIC = 36.33% (NOPAT 22.03b / Invested Capital 60.65b)
WACC = 8.50% (E(610.61b)/V(631.79b) * Re(8.77%) + D(21.18b)/V(631.79b) * Rd(0.92%) * (1-Tc(0.13)))
Discount Rate = 8.77% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.78%
[DCF] Terminal Value 77.47% ; FCFF base≈21.92b ; Y1≈23.73b ; Y5≈29.45b
[DCF] Fair Price = 272.3 (EV 464.21b - Net Debt 6.42b = Equity 457.79b / Shares 1.68b; r=8.50% [WACC]; 5y FCF grow 9.37% → 2.90% )
EPS Correlation: 97.65 | EPS CAGR: 16.46% | SUE: 0.63 | # QB: 0
Revenue Correlation: 98.92 | Revenue CAGR: 11.74% | SUE: 0.93 | # QB: 1
EPS next Quarter (2026-03-31): EPS=3.09 | Chg7d=+0.000 | Chg30d=+0.022 | Revisions Net=+19 | Analysts=28
EPS current Year (2026-09-30): EPS=12.85 | Chg7d=+0.001 | Chg30d=+0.053 | Revisions Net=+19 | Growth EPS=+12.0% | Growth Revenue=+11.5%
EPS next Year (2027-09-30): EPS=14.53 | Chg7d=+0.002 | Chg30d=+0.104 | Revisions Net=+22 | Growth EPS=+13.1% | Growth Revenue=+10.4%
[Analyst] Revisions Ratio: +0.76 (22 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.4% (Discount Rate 8.8% - Earnings Yield 3.4%)
[Growth] Growth Spread = +6.4% (Analyst 11.8% - Implied 5.4%)
P/E Forward = 26.9542
P/S = 14.7522
P/B = 17.767
P/EG = 1.9739
Revenue TTM = 41.39b USD
EBIT TTM = 25.32b USD
EBITDA TTM = 26.59b USD
Long Term Debt = 19.59b USD (from longTermDebt, last quarter)
Short Term Debt = 1.59b USD (from shortTermDebt, last quarter)
Debt = 21.18b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.42b USD (from netDebt column, last quarter)
Enterprise Value = 617.03b USD (610.61b + Debt 21.18b - CCE 14.76b)
Interest Coverage Ratio = 42.13 (Ebit TTM 25.32b / Interest Expense TTM 601.0m)
EV/FCF = 26.91x (Enterprise Value 617.03b / FCF TTM 22.93b)
FCF Yield = 3.72% (FCF TTM 22.93b / Enterprise Value 617.03b)
FCF Margin = 55.39% (FCF TTM 22.93b / Revenue TTM 41.39b)
Net Margin = 50.23% (Net Income TTM 20.79b / Revenue TTM 41.39b)
Gross Margin = 81.08% ((Revenue TTM 41.39b - Cost of Revenue TTM 7.83b) / Revenue TTM)
Gross Margin QoQ = 81.68% (prev 81.53%)
Tobins Q-Ratio = 6.37 (Enterprise Value 617.03b / Total Assets 96.81b)
Interest Expense / Debt = 0.92% (Interest Expense 194.0m / Debt 21.18b)
Taxrate = 12.98% (873.0m / 6.73b)
NOPAT = 22.03b (EBIT 25.32b * (1 - 12.98%))
Current Ratio = 1.11 (Total Current Assets 35.00b / Total Current Liabilities 31.49b)
Debt / Equity = 0.55 (Debt 21.18b / totalStockholderEquity, last quarter 38.78b)
Debt / EBITDA = 0.24 (Net Debt 6.42b / EBITDA 26.59b)
Debt / FCF = 0.28 (Net Debt 6.42b / FCF TTM 22.93b)
Total Stockholder Equity = 38.34b (last 4 quarters mean from totalStockholderEquity)
RoA = 22.04% (Net Income 20.79b / Total Assets 96.81b)
RoE = 54.22% (Net Income TTM 20.79b / Total Stockholder Equity 38.34b)
RoCE = 43.71% (EBIT 25.32b / Capital Employed (Equity 38.34b + L.T.Debt 19.59b))
RoIC = 36.33% (NOPAT 22.03b / Invested Capital 60.65b)
WACC = 8.50% (E(610.61b)/V(631.79b) * Re(8.77%) + D(21.18b)/V(631.79b) * Rd(0.92%) * (1-Tc(0.13)))
Discount Rate = 8.77% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.78%
[DCF] Terminal Value 77.47% ; FCFF base≈21.92b ; Y1≈23.73b ; Y5≈29.45b
[DCF] Fair Price = 272.3 (EV 464.21b - Net Debt 6.42b = Equity 457.79b / Shares 1.68b; r=8.50% [WACC]; 5y FCF grow 9.37% → 2.90% )
EPS Correlation: 97.65 | EPS CAGR: 16.46% | SUE: 0.63 | # QB: 0
Revenue Correlation: 98.92 | Revenue CAGR: 11.74% | SUE: 0.93 | # QB: 1
EPS next Quarter (2026-03-31): EPS=3.09 | Chg7d=+0.000 | Chg30d=+0.022 | Revisions Net=+19 | Analysts=28
EPS current Year (2026-09-30): EPS=12.85 | Chg7d=+0.001 | Chg30d=+0.053 | Revisions Net=+19 | Growth EPS=+12.0% | Growth Revenue=+11.5%
EPS next Year (2027-09-30): EPS=14.53 | Chg7d=+0.002 | Chg30d=+0.104 | Revisions Net=+22 | Growth EPS=+13.1% | Growth Revenue=+10.4%
[Analyst] Revisions Ratio: +0.76 (22 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.4% (Discount Rate 8.8% - Earnings Yield 3.4%)
[Growth] Growth Spread = +6.4% (Analyst 11.8% - Implied 5.4%)